What is the address of CENTRE MEDICAL OPHTALMOLOGIQUE JANSON?

The registered office of CENTRE MEDICAL OPHTALMOLOGIQUE JANSON is located at Paul Jansonlaan 78, 1070 Anderlecht.

Is CENTRE MEDICAL OPHTALMOLOGIQUE JANSON still active?

Yes. According to the CBE (28 September 2026) CENTRE MEDICAL OPHTALMOLOGIQUE JANSON is active, legal situation “Normale toestand”, started on 26 June 1988.

Is CENTRE MEDICAL OPHTALMOLOGIQUE JANSON registered on Peppol?

Yes, CENTRE MEDICAL OPHTALMOLOGIQUE JANSON is registered on the Peppol network with ID 0208:0434706587.

What is the enterprise number of CENTRE MEDICAL OPHTALMOLOGIQUE JANSON?

The enterprise number of CENTRE MEDICAL OPHTALMOLOGIQUE JANSON is BE0434706587.

When was CENTRE MEDICAL OPHTALMOLOGIQUE JANSON founded?

CENTRE MEDICAL OPHTALMOLOGIQUE JANSON was founded on 26 June 1988.

Who are the directors of CENTRE MEDICAL OPHTALMOLOGIQUE JANSON?

According to the 2024 annual accounts, the directors of CENTRE MEDICAL OPHTALMOLOGIQUE JANSON are: Charles CASTEL.

Is CENTRE MEDICAL OPHTALMOLOGIQUE JANSON a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 June 1988; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did CENTRE MEDICAL OPHTALMOLOGIQUE JANSON make in 2024?

CENTRE MEDICAL OPHTALMOLOGIQUE JANSON recorded a loss after taxes of € 10,864 in financial year 2024.

What is the revenue of CENTRE MEDICAL OPHTALMOLOGIQUE JANSON?

As a small company, CENTRE MEDICAL OPHTALMOLOGIQUE JANSON is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € -8,890.

CENTRE MEDICAL OPHTALMOLOGIQUE JANSON (Private Limited)

Dossier CENTRE MEDICAL OPHTALMOLOGIQUE JANSON, printed on 28 September 2026 from databakkes.be/en/0434706587/centre-medical-ophtalmologique-janson. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2023 and 2024.

Financials

Financial year 2024

CENTRE MEDICAL OPHTALMOLOGIQUE JANSON from Anderlecht, company number BE0434706587, closed financial year 2024 with a result of € -10,864 after tax. For that financial year CENTRE MEDICAL OPHTALMOLOGIQUE JANSON recorded a gross margin of € -8,890 and equity of € 12,390. Compared with financial year 2023, the result moved from € -6,815 to € -10,864. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 14, 2025.

What it is worth Healthy

€ 12,390

▼ 47% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -10,864

▼ 59 % more loss than in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 4,279

▼ 11% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -6,210.

People and assets in 2024

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 460

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ -17,126 Gross margin 2021: € -17,126 First fiscal year in the series	€ 23,166 Gross margin 2022: € 23,166 ▲ € 40,292 vs 2021 (€ -17,126) Favourable step	€ -5,016 Gross margin 2023: € -5,016 ▼ € 28,182 vs 2022 (€ 23,166) Unfavourable step	€ -8,890 Gross margin 2024: € -8,890 ▼ € 3,874 vs 2023 (€ -5,016) Unfavourable step	▼ € 3,874
Profit after taxes	€ -22,480 Profit after taxes 2021: € -22,480 First fiscal year in the series	€ 19,184 Profit after taxes 2022: € 19,184 ▲ € 41,664 vs 2021 (€ -22,480) Favourable step	€ -6,815 Profit after taxes 2023: € -6,815 ▼ € 25,998 vs 2022 (€ 19,184) Unfavourable step	€ -10,864 Profit after taxes 2024: € -10,864 ▼ € 4,049 vs 2023 (€ -6,815) Unfavourable step	▼ € 4,049
Equity	€ 10,884 Equity 2021: € 10,884 First fiscal year in the series	€ 30,068 Equity 2022: € 30,068 ▲ 176% vs 2021 (€ 10,884) Favourable step	€ 23,254 Equity 2023: € 23,254 ▼ 23% vs 2022 (€ 30,068) Unfavourable step	€ 12,390 Equity 2024: € 12,390 ▼ 47% vs 2023 (€ 23,254) Unfavourable step	▼ 47%
Total debts	€ 10,604 Total debts 2021: € 10,604 First fiscal year in the series	€ 10,231 Total debts 2022: € 10,231 ▼ 4% vs 2021 (€ 10,604) Favourable step	€ 334 Total debts 2023: € 334 ▼ 97% vs 2022 (€ 10,231) Favourable step	€ 167 Total debts 2024: € 167 ▼ 50% vs 2023 (€ 334) Favourable step	▼ 50%
Cash	€ 3,411 Cash 2021: € 3,411 First fiscal year in the series	€ 18,062 Cash 2022: € 18,062 ▲ € 14,650 vs 2021 (€ 3,411) Favourable step	€ 4,812 Cash 2023: € 4,812 ▼ 73% vs 2022 (€ 18,062) Unfavourable step	€ 4,279 Cash 2024: € 4,279 ▼ 11% vs 2023 (€ 4,812) Unfavourable step	▼ 11%
Retained profit	€ -7,716 Retained profit 2021: € -7,716 First fiscal year in the series	€ 11,468 Retained profit 2022: € 11,468 ▲ € 19,184 vs 2021 (€ -7,716) Favourable step	€ 4,654 Retained profit 2023: € 4,654 ▼ 59% vs 2022 (€ 11,468) Unfavourable step	€ -6,210 Retained profit 2024: € -6,210 ▼ € 10,864 vs 2023 (€ 4,654) Unfavourable step	▼ € 10,864
Balance sheet total	€ 21,488 Balance sheet total 2021: € 21,488 First fiscal year in the series	€ 40,299 Balance sheet total 2022: € 40,299 ▲ 88% vs 2021 (€ 21,488) Unchanged	€ 23,588 Balance sheet total 2023: € 23,588 ▼ 41% vs 2022 (€ 40,299) Unchanged	€ 12,557 Balance sheet total 2024: € 12,557 ▼ 47% vs 2023 (€ 23,588) Unchanged	▼ 47%

Key figures of CENTRE MEDICAL OPHTALMOLOGIQUE JANSON, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to CENTRE MEDICAL OPHTALMOLOGIQUE JANSON?

What happened at CENTRE MEDICAL OPHTALMOLOGIQUE JANSON in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 14, 2025 New annual accounts for financial year 2024: loss of € 10,864. filed late Source: NBB ↗
2023 Charles CASTEL became a director. NBB
Jun 26, 1998 New establishment in Anderlecht. KBO
Jun 26, 1988 Start of the company according to the CBE. KBO

In short

From € 22,480 loss in 2021 to € 10,864 loss in 2024.

Paid € 2,472 in corporate taxes since 2021.

Best year ever: 2022, with € 19,184 profit.

Original PDFs at the National Bank ↗

A new publication or filing at CENTRE MEDICAL OPHTALMOLOGIQUE JANSON? We notify you, reason included.

Follow CENTRE MEDICAL OPHTALMOLOGIQUE JANSON

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Charles CASTEL

CENTRE MEDICAL OPHTALMOLOGIQUE JANSON

Behind CENTRE MEDICAL OPHTALMOLOGIQUE JANSON is Charles CASTEL.

See the full network in the app

Directors

According to the 2024 annual accounts

Charles CASTEL

Manager

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Paul Jansonlaan 78

1070 Anderlecht

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0434.706.587
VAT number: BE 0434.706.587
Registered office: Paul Jansonlaan 78, 1070 Anderlecht
Names & denominations: CENTRE MEDICAL OPHTALMOLOGIQUE JANSON · C.M.O. JANSON
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 June 1988
Peppol: Active · Active since 8 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗